Propanc Biopharma, Inc. Contracts & Agreements

326 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 13, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2025
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 13, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due June 12, 2026 (with GEEBIS Consulting, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement between Propanc Biopharma, Inc. and Geebis Consulting, LLC dated June 12, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Loan Agreement between Propanc Biopharma Inc. and Aggro Investments Pty Ltd for AU$13,188
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Propanc Biopharma Inc. 10% OID Promissory Note Due July 15, 2025 (Ionic Ventures, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Underwriting Agreement between Propanc Biopharma, Inc. and D. Boral Capital LLC as Representative of the Underwriters
Underwriting Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2025
Propanc Biopharma Inc. 10% OID Promissory Note Due June 15, 2025 (Ionic Ventures, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Maturity Extension Agreement between Propanc Biopharma Inc. and Ionic Ventures, LLC (May 2025)
Modification Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due December 15, 2025 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated March 25, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2025
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated April 15, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated March 25, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2025
Loan Agreement between Propanc Biopharma Inc. and Aggro Investments Pty Ltd dated April 12, 2025
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Underwriting Agreement between Propanc Biopharma, Inc. and D. Boral Capital LLC as Representative of the Underwriters
Underwriting Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2025
Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Holder
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2025
Underwriting Agreement between Propanc Biopharma, Inc. and D. Boral Capital LLC as Representative of the Underwriters
Underwriting Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2025
Commercialization Agreement between Propanc Pty Ltd. and University of Bath Regarding Pro-Enzyme Technology
Collaboration Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Exchange Agreement between Propanc Biopharma, Inc. and Warrant Holder (March 3, 2025)
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Debt Exchange Agreement between Propane Biopharma, Inc. and Clark Hill PLLC dated March 5, 2025
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
MI
2025
Debt Exchange Agreement between Propanc Biopharma Inc. and Dr. Doug Mitchell (January 23, 2025)
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
FL
2025
Debt Exchange Agreement between Propanc Biopharma, Inc. and Notestar Pty Ltd dated February 5, 2025
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
FL
2025
Debt Exchange Agreement between Propanc Biopharma Inc. and Daisy Aronce (January 28, 2025)
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
FL
2025
Debt Exchange Agreement between Propanc Biopharma Inc. and GrantReady Pty Ltd as Trustee for GrantReady Group Trust No1
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
FL
2025
Debt Exchange Agreement between Propanc Biopharma, Inc. and Oxfel Pty Ltd dated February 5, 2025
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
FL
2025
Consulting Agreement between Propanc Biopharma Inc. and Gregory Harrison (February 2025)
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2025
Investor Relations Services Agreement between Propane Biopharma Inc. and Ross Silver
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
OR
2025
Share Issuance Agreement between Propanc and Brunson Chandler & Jones, PLLC
Stock Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Investor Relations Services Agreement between Propanc Biopharma Inc. and Krista Rash
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
OR
2025
Amended Independent Contractor Services Agreement between Propanc Biopharma, Inc. and Howard Isaacs & Richard Cavalli
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Capital Market Advisory Agreement between Propanc Biopharma, Inc. and Exchange Listing, LLC
Advisory Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2025
General Service Agreement between Propanc Biopharma and Enzyme Supplies Limited (February 10, 2025)
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Consulting and Stock Compensation Agreement between Propanc Biopharma and Dr. Ralf Brandt
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due November 11, 2025 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated March 11, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated January 31, 2025
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2025
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due October 7, 2025 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated January 31, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2025
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated February 7, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2025
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due June 15, 2025 (with GEEBIS Consulting, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Promissory Note between Propanc Biopharma, Inc. and Red Road Holdings Corporation dated December 4, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and Geebis Consulting, LLC dated December 13, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and Red Road Holdings Corporation dated December 4, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due March 20, 2025 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated September 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due February 2, 2025 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated August 2, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Loan Agreement between Propane Biopharma Inc. and Joshua Investments Pty Ltd (August 2024)
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Convertible Promissory Note between Propanc Biopharma, Inc. and 104 LLC dated June 20, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and 104 LLC dated June 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 10, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 10, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Loan Agreement between Propanc Biopharma Inc. and Susan Loizou dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement between Propanc Biopharma Inc. and Paul Mazor dated June 5, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement between Susan Loizou and Propane Biopharma Inc. dated June 3, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Loan Agreement between Propane Biopharma Inc. and Paul Mazor dated June 5, 2024
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated May 22, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated May 22, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Maturity Extension Agreement between Propanc Biopharma Inc. and Ionic Ventures, LLC (May 2024)
Modification Agreements
Propanc Biopharma, Inc.
Biotechnology
2024
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due October 12, 2024 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated April 12, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Convertible Promissory Note between Propanc Biopharma, Inc. and 104 LLC dated March 1, 2024
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement between Propanc Biopharma, Inc. and 104 LLC dated March 1, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Propanc Biopharma, Inc. 10% Convertible Redeemable Note Due December 8, 2024 (with ONE44 Capital LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and ONE44 Capital LLC dated December 8, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Convertible Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated November 29, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC (November 29, 2023)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Convertible Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated October 20, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated October 20, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due April 12, 2024 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated October 12, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due February 23, 2024 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated August 23, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Propanc Biopharma Inc. 10% OID Promissory Note Due November 15, 2023 (with Ionic Ventures, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Convertible Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated August 16, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated August 16, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Convertible Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated July 19, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC (July 19, 2023)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Common Stock Purchase Agreement between Propanc Biopharma, Inc. and Dutchess Capital Growth Fund L.P. dated July 20, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Registration Rights Agreement between Propanc Biopharma, Inc. and Dutchess Capital Growth Fund L.P. dated July 20, 2023
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Convertible Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 29, 2023
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 29, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Loan Agreement Between Aggro Investments Pty Ltd and Propanc Biopharma Inc. with Debt Warrant
Loan Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
10% Promissory Note between Propanc Biopharma, Inc. and Coventry Enterprises LLC dated November 3, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Securities Purchase Agreement between Propanc Biopharma, Inc. and Coventry Enterprises, LLC (November 3, 2022)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Common Stock Purchase Agreement between Propanc Biopharma Inc. and Coventry Enterprises, LLC (November 3, 2022)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Registration Rights Agreement between Propanc Biopharma, Inc. and Coventry Enterprises, LLC (November 3, 2022)
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Propanc Biopharma, Inc. and Ionic Ventures, LLC Warrant Exercise Inducement Agreement (March 2023)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Propanc Biopharma, Inc. 10% Convertible Redeemable Note Due February 14, 2024 (with ONE44 Capital LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Amended and Restated Employment Agreement between Propanc Biopharma, Inc. and James Nathanielsz
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2022
Convertible Promissory Note between Propanc Biopharma, Inc. and Red Road Holdings Corporation dated October 6, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and Red Road Holdings Corporation dated October 6, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due March 21, 2023 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated September 21, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due April 12, 2023 (with GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Propanc Biopharma, Inc. 10% Convertible Redeemable Note Due August 15, 2023 (with ONE44 Capital LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated August 12, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and ONE44 Capital LLC dated August 15, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Convertible Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 30, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated June 30, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Convertible Promissory Note between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated May 12, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and 1800 Diagonal Lending LLC dated May 12, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Convertible Promissory Note between Propanc Biopharma, Inc. and Sixth Street Lending LLC dated April 12, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and Sixth Street Lending LLC dated April 12, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Propanc Biopharma, Inc. 10% Convertible Redeemable Note Due March 29, 2023 (with ONE44 Capital LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and ONE44 Capital LLC dated March 29, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Convertible Promissory Note between Propanc Biopharma, Inc. and Sixth Street Lending LLC dated March 7, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and Sixth Street Lending LLC dated March 7, 2022
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Convertible Promissory Note between Propanc Biopharma, Inc. and Sixth Street Lending LLC dated January 4, 2022
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement between Propanc Biopharma, Inc. and Sixth Street Lending LLC (January 2022)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Propanc Biopharma, Inc. 10% Convertible Redeemable Note Due December 7, 2022 (with ONE44 Capital LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2021
Securities Purchase Agreement between Propanc Biopharma, Inc. and ONE44 Capital LLC dated December 7, 2021
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2021
Common Stock Purchase Agreement between Propanc Biopharma, Inc. and Dutchess Capital Growth Fund LP (November 30, 2021)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2021
Registration Rights Agreement between Propanc Biopharma, Inc. and Dutchess Capital Growth Fund LP (November 30, 2021)
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2021
Convertible Promissory Note between Propanc Biopharma, Inc. and Sixth Street Lending LLC dated November 26, 2021
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Securities Purchase Agreement between Propanc Biopharma, Inc. and Sixth Street Lending LLC (November 2021)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Consulting Agreement between Apogee Partners LLC and Propane Biopharma, Inc.
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
NJ
2021
Convertible Promissory Note between Propanc Biopharma, Inc. and Sixth Street Lending LLC dated October 21, 2021
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Securities Purchase Agreement between Propanc Biopharma, Inc. and Sixth Street Lending LLC (October 2021)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Convertible Promissory Note between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated September 22, 2021
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated September 22, 2021
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Convertible Promissory Note between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated August 19, 2021
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated August 19, 2021
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Cancellation Agreement between Propanc Biopharma, Inc. and James Nathanielsz (August 12, 2021)
Release Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2021
Cancellation Agreement between Propanc Biopharma, Inc. and Dr. Julian Kenyon (August 12, 2021)
Release Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2021
Amended and Restated Director Agreement between Propanc Biopharma, Inc. and Josef Zelinger
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
2021
Convertible Promissory Note between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated March 16, 2021
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated March 16, 2021
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Convertible Promissory Note between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated January 5, 2021
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated January 5, 2021
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Director Agreement between Propanc Biopharma, Inc. and Josef Zelinger dated December 23, 2020
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Indemnification Agreement between Propanc Biopharma, Inc. and Josef Zelinger (December 23, 2020)
Indemnification Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2020
Propanc Biopharma Inc. 8% Convertible Redeemable Promissory Note with GW Holdings Group, LLC (December 2020)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Securities Purchase Agreement between Propanc Biopharma Inc. and GW Holdings Group, LLC dated December 10, 2020
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Convertible Promissory Note between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated December 2, 2020
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between Propanc Biopharma, Inc. and Geneva Roth Remark Holdings, Inc. dated December 2, 2020
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Prefunded Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Holder (March 30, 2020)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Series A Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Holder (March 30, 2020)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Series B Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Holder (March 30, 2020)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Propanc Biopharma, Inc. Series C Common Stock Purchase Warrant Agreement (March 30, 2020)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Securities Purchase Agreement between Propanc Biopharma, Inc. and Purchasers dated March 30, 2020
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Registration Rights Agreement between Propanc Biopharma, Inc. and Purchasers Dated March 30, 2020
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2020
Convertible Promissory Note between Propanc Biopharma, Inc. and Holder, Dated January 2020
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due January 13, 2021
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between Propanc Biopharma, Inc. and Buyer (January 2020)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between Propanc Biopharma, Inc. and Buyer (January 13, 2020)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020
Convertible Promissory Note between Propanc Biopharma, Inc. and Crown Bridge Partners, LLC dated October 3, 2019
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Propanc Biopharma, Inc. and Crown Bridge Partners, LLC dated October 3, 2019
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Propanc Biopharma Inc. 8% Convertible Redeemable Promissory Note (Due October 1, 2020)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2019
Securities Purchase Agreement between Propanc Biopharma Inc. and Buyer (October 1, 2019)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Convertible Promissory Note between Propanc Biopharma, Inc. and Auctus Fund, LLC dated August 30, 2019
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Auctus Fund, LLC (August 30, 2019)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Auctus Fund, LLC (August 30, 2019)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Auctus Fund, LLC (August 30, 2019)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Securities Purchase Agreement between Propanc Biopharma, Inc. and Auctus Fund, LLC dated August 30, 2019
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Registration Rights Agreement between Propanc Biopharma, Inc. and Auctus Fund, LLC dated August 30, 2019
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
MA
2019
Propanc Biopharma, Inc. 10% Convertible Redeemable Note Due July 30, 2020 (with Odyssey Capital Funding, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Propanc Biopharma, Inc. and Odyssey Capital Funding LLC dated July 30, 2019
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Convertible Promissory Note between Propanc Biopharma, Inc. and Power Up Lending Group Ltd. dated July 3, 2019
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Propanc Biopharma, Inc. and Power Up Lending Group Ltd. dated July 3, 2019
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Employment Agreement between Propanc Pty Ltd and Carlo Campiciano
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2019
Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Holder
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Holder
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Common Stock Purchase Warrant Agreement between Propanc Biopharma, Inc. and Holder
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Propanc Biopharma, Inc. and Purchasers (June 2019)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Placement Agency Agreement between Propanc Biopharma, Inc. and Roth Capital Partners, LLC (June 2019)
Underwriting Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Convertible Promissory Note between Propanc Biopharma, Inc. and Redstart Holdings Corp. dated May 23, 2019
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Propanc Biopharma, Inc. and Redstart Holdings Corp. dated May 23, 2019
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Amended and Restated Employment Agreement between Propanc Biopharma, Inc. and James Nathanielsz (May 14, 2019)
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Amended and Restated Services Agreement between Julian Kenyon and Propanc Biopharma, Inc.
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Propanc Biopharma, Inc. 2019 Equity Incentive Plan
Equity Distribution Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2019
Indemnification Agreement between Propanc Biopharma, Inc. and Indemnitee
Indemnification Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2019
Equity Purchase Agreement between Propanc Biopharma, Inc. and Oasis Capital, LLC dated February 25, 2019
Equity Distribution Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Registration Rights Agreement between Propanc Biopharma, Inc. and Oasis Capital, LLC dated February 25, 2019
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2019
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due December 24, 2019 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated December 24, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due November 30, 2019 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated November 30, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Equity Purchase Agreement between Propanc Biopharma, Inc. and L2 Capital, LLC dated October 5, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Registration Rights Agreement between Propanc Biopharma, Inc. and L2 Capital, LLC dated October 5, 2018
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due October 2, 2019 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due October 2, 2019 (with GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due October 2, 2019 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Collateralized Secured Promissory Note between GS Capital Partners, LLC and Propanc Biopharma, Inc. dated October 2, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated October 2, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated October 2, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Amendment to Employment Agreement between Propanc Biopharma, Inc. and James Nathanielsz
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement between Propanc Biopharma Inc. and Power Up Lending Group Ltd. dated August 28, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Convertible Promissory Note between Propanc Biopharma Inc. and Power Up Lending Group Ltd. dated August 28, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated August 29, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due August 29, 2019 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated July 13, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due July 13, 2019 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Coventry Enterprises, LLC dated June 29, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due June 29, 2019 (Coventry Enterprises, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due June 29, 2019 (Coventry Enterprises, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Collateralized Secured Promissory Note between Coventry Enterprises, LLC and Propanc Biopharma, Inc. dated June 29, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
8% Convertible Promissory Note between Propanc Biopharma, Inc. and JSJ Investments Inc. dated June 26, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated June 14, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due June 14, 2019 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated April 13, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due April 13, 2019 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due April 13, 2019 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
GS Capital Partners, LLC Collateralized Secured Promissory Note with Propanc Biopharma, Inc. dated April 13, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated March 23, 2018
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Junior Subordinated Note Due March 21, 2019 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Junior Subordinated Note Due March 21, 2019 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Collateralized Secured Promissory Note between GS Capital Partners, LLC and Propanc Biopharma, Inc. dated March 23, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2018
Securities Purchase Agreement between Propanc Biopharma Inc. and Power Up Lending Group Ltd.
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Convertible Promissory Note between Propanc Biopharma Inc. and Power Up Lending Group Ltd. dated January 22, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated December 29, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Note Due December 29, 2018 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2018
Propanc Biopharma, Inc. 8% Convertible Redeemable Junior Subordinated Note Due October 25, 2018 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Propanc Biopharma, Inc. 8% Convertible Redeemable Junior Subordinated Note Due October 25, 2018 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Collateralized Secured Promissory Note between Eagle Equities, LLC and Propanc Biopharma, Inc. dated October 25, 2017
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Securities Purchase Agreement between Propanc Biopharma, Inc. and Eagle Equities, LLC dated October 25, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Maturity Date Extension Agreement between Delafield Investments Limited and Propanc Biopharma, Inc.
Modification Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Junior Subordinated Convertible Note Agreement between Propanc Biopharma, Inc. and Regal Consulting
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Consulting Agreement between Regal Consulting and Propanc Biopharma, Inc.
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Propanc Biopharma, Inc. 8% Convertible Redeemable Junior Subordinated Note Due July 24, 2018 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Propanc Biopharma, Inc. 8% Convertible Redeemable Junior Subordinated Note Due July 24, 2018 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Collateralized Secured Promissory Note between GS Capital Partners, LLC and Propanc Biopharma, Inc. dated July 24, 2017
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated July 24, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Securities Purchase Agreement between Propanc Biopharma, Inc. and GS Capital Partners, LLC dated July 24, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due May 17, 2018 (GS Capital Partners, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Securities Purchase Agreement between Propanc Health Group Corporation and GS Capital Partners, LLC dated May 8, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due March 1, 2018 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due March 1, 2018 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Securities Purchase Agreement between Propanc Health Group Corporation and Eagle Equities, LLC dated March 1, 2017
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Maturity Date Extension Agreement between Delafield Investments Limited and Propanc Health Group Corporation
Modification Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due January 27, 2018 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due January 27, 2018 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2017
Securities Purchase Agreement between Propanc Health Group Corporation and Eagle Equities, LLC (January 27, 2017)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2017
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due December 21, 2017 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due December 21, 2017 (with Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Securities Purchase Agreement between Propanc Health Group Corporation and Eagle Equities, LLC (December 21, 2016)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Propanc Health Group Corporation 8% Convertible Redeemable Promissory Note Due December 2, 2018
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Propanc Health Group Corporation Common Stock Purchase Warrant Agreement with Delafield Investments Limited (December 2, 2016)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Junior Subordinated Promissory Note between Propanc Health Group Corporation and GHS Investments, LLC
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Unsecured Junior Subordinated Promissory Note between Propanc Health Group Corporation and GHS Investments LLC (Due June 1, 2017)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Warrant Cancellation and Convertible Note Exchange Agreement between Propanc Health Group Corporation and Delafield Investments Limited
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Equity Financing Agreement between Propanc Health Group Corporation and GHS Investments LLC (December 1, 2016)
Equity Distribution Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Registration Rights Agreement between Propanc Health Group Corporation and GHS Investments LLC (December 1, 2016)
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Junior Subordinated Convertible Note Agreement between Propanc Health Group Corporation and Regal Consulting
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Junior Subordinated Convertible Note between Propanc Health Group Corporation and Regal Consulting
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Consulting Agreement between Regal Consulting and Propanc Health Group Corporation
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due October 31, 2017 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Propanc Health Group Corp. 8% Convertible Redeemable Junior Subordinated Note Due October 31, 2017 (Eagle Equities, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Securities Purchase Agreement between Propanc Health Group Corporation and Eagle Equities, LLC (October 31, 2016)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Collateralized Secured Promissory Note between Eagle Equities, LLC and Propanc Health Group Corporation dated October 31, 2016
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
5% Original Issue Discount Senior Secured Convertible Debenture between Propanc Health Group Corporation and Delafield Investments Limited
Debenture Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Additional Issuance Agreement between Propanc Health Group Corporation and Delafield Investments Limited (September 13, 2016)
Debenture Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Manufacturing Services Agreement between Propanc Health Group Corporation and Q-Biologicals NV
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Quality Assurance Agreement between Propanc Health Group Corporation and Q-Biologicals NV (August 12, 2016)
Collaboration Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Common Stock Purchase Warrant Agreement between Propanc Health Group Corporation and Delafield Investments Limited (August 3, 2016)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Common Stock Purchase Warrant Agreement between Propanc Health Group Corporation and Delafield Investments Limited (August 3, 2016)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2016
Debenture Extension and Warrant Issuance Agreement between Propanc Health Group Corp. and Delafield Investments Limited
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Warrant Exercise and Repricing Agreement between Propanc Health Group Corp. and Delafield Investments Ltd. (July 1, 2016)
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Amendment No. 1 to Employment Agreement between Propanc Health Group Corporation and James Nathanielsz
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Employment Agreement between ProPanc Health Group Corporation and James Nathanielsz (2015)
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2016
Director Agreement between ProPanc Health Group Corporation and Julian Keyon
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2016
Scientific Advisory Board Member Agreement between Propanc Pty Ltd and [SAB Member]
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
Addendum to Securities Purchase Agreement between Propanc Health Group Corp. and Purchaser (March 11, 2016)
Modification Agreements
Propanc Biopharma, Inc.
Biotechnology
2016
5% Original Issue Discount Senior Secured Convertible Debenture between Propanc Health Group Corp. and Delafield Investments Limited (October 28, 2015)
Debenture Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Common Stock Purchase Warrant Agreement between Propanc Health Group Corp. and Delafield Investments Limited
Warrant Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Securities Purchase Agreement between Propanc Health Group Corp. and Purchaser (October 2015)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Registration Rights Agreement between Propanc Health Group Corp. and Purchaser (October 2015)
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Security Agreement among Propanc Health Group Corp., Subsidiaries, and Debenture Holder (October 2015)
Security Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Promissory Note between Propanc Health Group Corp. and MG Partners II Limited dated September 24, 2015
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Security Agreement among Propanc Health Group Corp., Subsidiaries, and Debenture Holder Dated September 24, 2015
Security Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Certificate of Designation of Series B Preferred Stock of Propanc Health Group Corporation
Articles of Amendment
Propanc Biopharma, Inc.
Biotechnology
DE
2015
Convertible Promissory Note between Propanc Health Group Corporation and KBM Worldwide, Inc. dated January 26, 2015
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due February 10, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due February 10, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Collateralized Secured Promissory Note between Union Capital, LLC and Propanc Health Group Corp.
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due February 17, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due February 17, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Collateralized Secured Promissory Note between Union Capital, LLC and Propanc Health Group Corp.
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due March 12, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due March 12, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Collateralized Secured Promissory Note between Union Capital, LLC and Propanc Health Group Corp.
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due March 20, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due March 20, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Union Capital, LLC Collateralized Secured Promissory Note with Propanc Health Group Corp.
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due March 4, 2016 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Convertible Promissory Note between Propanc Health Group Corp. and Carebourn Capital, L.P. dated February 20, 2015
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
IL
2015
Securities Purchase Agreement between Propanc Health Group Corporation and KBM Worldwide, Inc. dated January 26, 2015
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Convertible Promissory Note between Propanc Health Group Corporation and Vis Vires Group, Inc. dated March 12, 2015
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Propanc Health Group Corporation and KBM Worldwide, Inc. (January 26, 2015)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Propanc Health Group Corp. and Union Capital, LLC (February 10, 2015)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Propanc Health Group Corp. and Union Capital, LLC (February 17, 2015)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Propanc Health Group Corp. and Union Capital, LLC dated March 12, 2015
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Propanc Health Group Corp. and Union Capital, LLC (March 20, 2015)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between Propanc Health Group Corp. and Carebourn Capital, L.P. (February 20, 2015)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
IL
2015
Securities Purchase Agreement between Propanc Health Group Corporation and Vis Vires Group, Inc. dated March 12, 2015
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2015
Debt Settlement and Release Agreement between Propanc Health Group Corporation, Propanc PTY Ltd., and James Nathanielsz (February 2015)
Settlement Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Debt Settlement and Release Agreement between Propanc Health Group Corporation, Propanc PTY Ltd., and Julian Kenyon (February 4, 2015)
Settlement Agreements
Propanc Biopharma, Inc.
Biotechnology
2015
Propanc Health Group Corp. 8% Convertible Redeemable Note Due May 30, 2015 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Propanc Health Group Corp. 8% Convertible Redeemable Note Due May 30, 2015 (Union Capital, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Collateralized Secured Promissory Note between Union Capital, LLC and Propanc Health Group Corp.
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Propanc Health Group Corp. 8% Convertible Redeemable Note Due May 29, 2015 (LG Capital Funding, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Propanc Health Group Corp. 8% Convertible Redeemable Note Due May 29, 2015 (LG Capital Funding, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Collateralized Secured Promissory Note between LG Capital Funding, LLC and Propanc Health Group Corp.
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Propanc Health Group Corp. 8% Convertible Redeemable Note Due May 29, 2015 (Adar Bays, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Propanc Health Group Corp. 8% Convertible Redeemable Note Due May 29, 2015 (Adar Bays, LLC)
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Collateralized Secured Promissory Note between Adar Bays, LLC and Propanc Health Group Corp.
Note Agreements
Propanc Biopharma, Inc.
Biotechnology
2014
Securities Purchase Agreement between Propanc Health Group Corp. and Union Capital, LLC (May 30, 2014)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
Securities Purchase Agreement between Propanc Health Group Corp. and LG Capital Funding, LLC (May 29, 2014)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
Securities Purchase Agreement between Propanc Health Group Corp. and ADAR BAYS, LLC (May 29, 2014)
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
Settlement Agreement and Stipulation between Tarpon Bay Partners LLC and Propanc Health Group Corporation (July 18, 2014)
Settlement Agreements
Propanc Biopharma, Inc.
Biotechnology
FL
2014
Equity Purchase Agreement between Propanc Health Group Corporation and Southridge Partners II LP
Equity Distribution Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
Registration Rights Agreement between Propanc Health Group Corporation and Southridge Partners II LP
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2014
Escrow Deposit Agreement between Propanc Health Group Corporation and Signature Bank (November 2011)
Escrow Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2011
Propanc Health Group Corporation Subscription Agreement for Common Stock Purchase
Subscription Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Limited Distributor Deed between Propanc Pty. Ltd. and European Nutripharm Ltd. (May 7, 2008)
Distribution Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Investment Banking and Listing Agreement between Propanc Pty Ltd. and Churchill & Associates, LLC (August 3, 2010)
Investment Agreements
Propanc Biopharma, Inc.
Biotechnology
GA
2011
Investment Banking and Listing Agreement between Propanc Pty Ltd. and Churchill & Associates, LLC (September 16, 2010)
Investment Agreements
Propanc Biopharma, Inc.
Biotechnology
GA
2011
Termination Letter for Investment Banking & Listing Agreements between Propanc Health Group Corporation and Churchill and Associates, LLC
Termination Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Research Engagement Agreement between Propanc Pty Ltd and Dr. Paul Clayton
Services Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Letter of Appointment for Dr. Julian Kenyon as Scientific Director and Board Member of Propanc Pty Ltd
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Director Appointment Letter between Propanc Pty Ltd and Dr. Douglas Mitchell
Consulting Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Research Agreement between University of Bath and Propanc Pty Ltd for Pro-Enzyme Anti-Cancer Technology
Collaboration Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Employment Agreement between Propanc Pty Limited and James Nathanielsz (Managing Director)
Employment Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Propanc Health Group Corporation Offer to Exchange Shares with Propanc Pty Ltd Shareholders
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
2011
Registration Rights Agreement between Propanc Health Group Corporation and Investor (2010)
Registration Rights Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2011
Exchange Offer Subscription Agreement between Propanc Health Group Corporation and Non-U.S. Investor
Exchange Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2011